New-onset IgG autoantibodies in hospitalized patients with COVID-19
Infection with SARS-CoV2 and the development of Coronavirus disease 2019 (COVID-19) has been linked to induction of autoimmunity and autoantibody production. Here the authors characterise the new-onset IgG autoantibody response in hospitalised patients with COVID-19 which they correlate to the magni...
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-09-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-021-25509-3 |
id |
doaj-66cae071533b4d708afeb170397e48a7 |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Sarah Esther Chang Allan Feng Wenzhao Meng Sokratis A. Apostolidis Elisabeth Mack Maja Artandi Linda Barman Kate Bennett Saborni Chakraborty Iris Chang Peggie Cheung Sharon Chinthrajah Shaurya Dhingra Evan Do Amanda Finck Andrew Gaano Reinhard Geßner Heather M. Giannini Joyce Gonzalez Sarah Greib Margrit Gündisch Alex Ren Hsu Alex Kuo Monali Manohar Rong Mao Indira Neeli Andreas Neubauer Oluwatosin Oniyide Abigail E. Powell Rajan Puri Harald Renz Jeffrey Schapiro Payton A. Weidenbacher Richard Wittman Neera Ahuja Ho-Ryun Chung Prasanna Jagannathan Judith A. James Peter S. Kim Nuala J. Meyer Kari C. Nadeau Marko Radic William H. Robinson Upinder Singh Taia T. Wang E. John Wherry Chrysanthi Skevaki Eline T. Luning Prak Paul J. Utz |
spellingShingle |
Sarah Esther Chang Allan Feng Wenzhao Meng Sokratis A. Apostolidis Elisabeth Mack Maja Artandi Linda Barman Kate Bennett Saborni Chakraborty Iris Chang Peggie Cheung Sharon Chinthrajah Shaurya Dhingra Evan Do Amanda Finck Andrew Gaano Reinhard Geßner Heather M. Giannini Joyce Gonzalez Sarah Greib Margrit Gündisch Alex Ren Hsu Alex Kuo Monali Manohar Rong Mao Indira Neeli Andreas Neubauer Oluwatosin Oniyide Abigail E. Powell Rajan Puri Harald Renz Jeffrey Schapiro Payton A. Weidenbacher Richard Wittman Neera Ahuja Ho-Ryun Chung Prasanna Jagannathan Judith A. James Peter S. Kim Nuala J. Meyer Kari C. Nadeau Marko Radic William H. Robinson Upinder Singh Taia T. Wang E. John Wherry Chrysanthi Skevaki Eline T. Luning Prak Paul J. Utz New-onset IgG autoantibodies in hospitalized patients with COVID-19 Nature Communications |
author_facet |
Sarah Esther Chang Allan Feng Wenzhao Meng Sokratis A. Apostolidis Elisabeth Mack Maja Artandi Linda Barman Kate Bennett Saborni Chakraborty Iris Chang Peggie Cheung Sharon Chinthrajah Shaurya Dhingra Evan Do Amanda Finck Andrew Gaano Reinhard Geßner Heather M. Giannini Joyce Gonzalez Sarah Greib Margrit Gündisch Alex Ren Hsu Alex Kuo Monali Manohar Rong Mao Indira Neeli Andreas Neubauer Oluwatosin Oniyide Abigail E. Powell Rajan Puri Harald Renz Jeffrey Schapiro Payton A. Weidenbacher Richard Wittman Neera Ahuja Ho-Ryun Chung Prasanna Jagannathan Judith A. James Peter S. Kim Nuala J. Meyer Kari C. Nadeau Marko Radic William H. Robinson Upinder Singh Taia T. Wang E. John Wherry Chrysanthi Skevaki Eline T. Luning Prak Paul J. Utz |
author_sort |
Sarah Esther Chang |
title |
New-onset IgG autoantibodies in hospitalized patients with COVID-19 |
title_short |
New-onset IgG autoantibodies in hospitalized patients with COVID-19 |
title_full |
New-onset IgG autoantibodies in hospitalized patients with COVID-19 |
title_fullStr |
New-onset IgG autoantibodies in hospitalized patients with COVID-19 |
title_full_unstemmed |
New-onset IgG autoantibodies in hospitalized patients with COVID-19 |
title_sort |
new-onset igg autoantibodies in hospitalized patients with covid-19 |
publisher |
Nature Publishing Group |
series |
Nature Communications |
issn |
2041-1723 |
publishDate |
2021-09-01 |
description |
Infection with SARS-CoV2 and the development of Coronavirus disease 2019 (COVID-19) has been linked to induction of autoimmunity and autoantibody production. Here the authors characterise the new-onset IgG autoantibody response in hospitalised patients with COVID-19 which they correlate to the magnitude of the SARS-CoV2 response. |
url |
https://doi.org/10.1038/s41467-021-25509-3 |
work_keys_str_mv |
AT sarahestherchang newonsetiggautoantibodiesinhospitalizedpatientswithcovid19 AT allanfeng newonsetiggautoantibodiesinhospitalizedpatientswithcovid19 AT wenzhaomeng newonsetiggautoantibodiesinhospitalizedpatientswithcovid19 AT sokratisaapostolidis newonsetiggautoantibodiesinhospitalizedpatientswithcovid19 AT elisabethmack newonsetiggautoantibodiesinhospitalizedpatientswithcovid19 AT majaartandi newonsetiggautoantibodiesinhospitalizedpatientswithcovid19 AT lindabarman newonsetiggautoantibodiesinhospitalizedpatientswithcovid19 AT katebennett newonsetiggautoantibodiesinhospitalizedpatientswithcovid19 AT sabornichakraborty newonsetiggautoantibodiesinhospitalizedpatientswithcovid19 AT irischang newonsetiggautoantibodiesinhospitalizedpatientswithcovid19 AT peggiecheung newonsetiggautoantibodiesinhospitalizedpatientswithcovid19 AT sharonchinthrajah newonsetiggautoantibodiesinhospitalizedpatientswithcovid19 AT shauryadhingra newonsetiggautoantibodiesinhospitalizedpatientswithcovid19 AT evando newonsetiggautoantibodiesinhospitalizedpatientswithcovid19 AT amandafinck newonsetiggautoantibodiesinhospitalizedpatientswithcovid19 AT andrewgaano newonsetiggautoantibodiesinhospitalizedpatientswithcovid19 AT reinhardgeßner newonsetiggautoantibodiesinhospitalizedpatientswithcovid19 AT heathermgiannini newonsetiggautoantibodiesinhospitalizedpatientswithcovid19 AT joycegonzalez newonsetiggautoantibodiesinhospitalizedpatientswithcovid19 AT sarahgreib newonsetiggautoantibodiesinhospitalizedpatientswithcovid19 AT margritgundisch newonsetiggautoantibodiesinhospitalizedpatientswithcovid19 AT alexrenhsu newonsetiggautoantibodiesinhospitalizedpatientswithcovid19 AT alexkuo newonsetiggautoantibodiesinhospitalizedpatientswithcovid19 AT monalimanohar newonsetiggautoantibodiesinhospitalizedpatientswithcovid19 AT rongmao newonsetiggautoantibodiesinhospitalizedpatientswithcovid19 AT indiraneeli newonsetiggautoantibodiesinhospitalizedpatientswithcovid19 AT andreasneubauer newonsetiggautoantibodiesinhospitalizedpatientswithcovid19 AT oluwatosinoniyide newonsetiggautoantibodiesinhospitalizedpatientswithcovid19 AT abigailepowell newonsetiggautoantibodiesinhospitalizedpatientswithcovid19 AT rajanpuri newonsetiggautoantibodiesinhospitalizedpatientswithcovid19 AT haraldrenz newonsetiggautoantibodiesinhospitalizedpatientswithcovid19 AT jeffreyschapiro newonsetiggautoantibodiesinhospitalizedpatientswithcovid19 AT paytonaweidenbacher newonsetiggautoantibodiesinhospitalizedpatientswithcovid19 AT richardwittman newonsetiggautoantibodiesinhospitalizedpatientswithcovid19 AT neeraahuja newonsetiggautoantibodiesinhospitalizedpatientswithcovid19 AT horyunchung newonsetiggautoantibodiesinhospitalizedpatientswithcovid19 AT prasannajagannathan newonsetiggautoantibodiesinhospitalizedpatientswithcovid19 AT judithajames newonsetiggautoantibodiesinhospitalizedpatientswithcovid19 AT peterskim newonsetiggautoantibodiesinhospitalizedpatientswithcovid19 AT nualajmeyer newonsetiggautoantibodiesinhospitalizedpatientswithcovid19 AT karicnadeau newonsetiggautoantibodiesinhospitalizedpatientswithcovid19 AT markoradic newonsetiggautoantibodiesinhospitalizedpatientswithcovid19 AT williamhrobinson newonsetiggautoantibodiesinhospitalizedpatientswithcovid19 AT upindersingh newonsetiggautoantibodiesinhospitalizedpatientswithcovid19 AT taiatwang newonsetiggautoantibodiesinhospitalizedpatientswithcovid19 AT ejohnwherry newonsetiggautoantibodiesinhospitalizedpatientswithcovid19 AT chrysanthiskevaki newonsetiggautoantibodiesinhospitalizedpatientswithcovid19 AT elinetluningprak newonsetiggautoantibodiesinhospitalizedpatientswithcovid19 AT pauljutz newonsetiggautoantibodiesinhospitalizedpatientswithcovid19 |
_version_ |
1717375513539903488 |
spelling |
doaj-66cae071533b4d708afeb170397e48a72021-09-19T11:48:29ZengNature Publishing GroupNature Communications2041-17232021-09-0112111510.1038/s41467-021-25509-3New-onset IgG autoantibodies in hospitalized patients with COVID-19Sarah Esther Chang0Allan Feng1Wenzhao Meng2Sokratis A. Apostolidis3Elisabeth Mack4Maja Artandi5Linda Barman6Kate Bennett7Saborni Chakraborty8Iris Chang9Peggie Cheung10Sharon Chinthrajah11Shaurya Dhingra12Evan Do13Amanda Finck14Andrew Gaano15Reinhard Geßner16Heather M. Giannini17Joyce Gonzalez18Sarah Greib19Margrit Gündisch20Alex Ren Hsu21Alex Kuo22Monali Manohar23Rong Mao24Indira Neeli25Andreas Neubauer26Oluwatosin Oniyide27Abigail E. Powell28Rajan Puri29Harald Renz30Jeffrey Schapiro31Payton A. Weidenbacher32Richard Wittman33Neera Ahuja34Ho-Ryun Chung35Prasanna Jagannathan36Judith A. James37Peter S. Kim38Nuala J. Meyer39Kari C. Nadeau40Marko Radic41William H. Robinson42Upinder Singh43Taia T. Wang44E. John Wherry45Chrysanthi Skevaki46Eline T. Luning Prak47Paul J. Utz48Department of Medicine, Division of Immunology and Rheumatology, Stanford University School of MedicineDepartment of Medicine, Division of Immunology and Rheumatology, Stanford University School of MedicineDepartment of Pathology and Laboratory Medicine, Perelman School of Medicine, University of PennsylvaniaDepartment of Medicine, Division of Rheumatology, Perelman School of Medicine, University of PennsylvaniaDepartment of Hematology, Oncology, Immunology, Philipps University MarburgDepartment of Medicine, Division of Primary Care and Population Health, Stanford University School of MedicineDepartment of Medicine, Division of Primary Care and Population Health, Stanford University School of MedicineMolecular Pathology and Imaging Core, Department of Medicine, Gastroenterology Division, Perelman School of Medicine, University of PennsylvaniaDepartment of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford University School of MedicineInstitute for Immunity, Transplantation and Infection, Stanford University School of MedicineDepartment of Medicine, Division of Immunology and Rheumatology, Stanford University School of MedicineInstitute for Immunity, Transplantation and Infection, Stanford University School of MedicineDepartment of Medicine, Division of Immunology and Rheumatology, Stanford University School of MedicineInstitute for Immunity, Transplantation and Infection, Stanford University School of MedicineDepartment of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of PennsylvaniaDepartment of Pathology and Laboratory Medicine, Perelman School of Medicine, University of PennsylvaniaInstitute of Laboratory Medicine, Philipps University MarburgDepartment of Microbiology, Immunology and Biochemistry, The University of Tennessee Health Science CenterDepartment of Pathology and Laboratory Medicine, Perelman School of Medicine, University of PennsylvaniaInstitute of Laboratory Medicine, Philipps University MarburgInstitute of Laboratory Medicine, Philipps University MarburgDepartment of Medicine, Division of Immunology and Rheumatology, Stanford University School of MedicineDepartment of Medicine, Division of Immunology and Rheumatology, Stanford University School of MedicineInstitute for Immunity, Transplantation and Infection, Stanford University School of MedicineDepartment of Medicine, Division of Immunology and Rheumatology, Stanford University School of MedicineDepartment of Microbiology, Immunology and Biochemistry, The University of Tennessee Health Science CenterDepartment of Hematology, Oncology, Immunology, Philipps University MarburgDepartment of Medicine, Division of Pulmonary, Allergy, and Critical Care Medicine, Perelman School of Medicine, University of PennsylvaniaDepartment of Biochemistry, Stanford University School of MedicineDepartment of Medicine, Division of Primary Care and Population Health, Stanford University School of MedicineInstitute of Laboratory Medicine, Philipps University MarburgTPMG Regional Reference Laboratory, Kaiser Permanente Northern CaliforniaDepartment of Biochemistry, Stanford University School of MedicineDepartment of Medicine, Division of Primary Care and Population Health, Stanford University School of MedicineDepartment of Medicine, Division of Hospital Medicine, Stanford University School of MedicineInstitute for Medical Bioinformatics and Biostatistics, Philipps University MarburgInstitute for Immunity, Transplantation and Infection, Stanford University School of MedicineArthritis & Clinical Immunology Program, Oklahoma Medical Research FoundationDepartment of Microbiology, Immunology and Biochemistry, The University of Tennessee Health Science CenterInstitute for Immunology, Perelman School of Medicine, University of PennsylvaniaInstitute for Immunity, Transplantation and Infection, Stanford University School of MedicineDepartment of Microbiology, Immunology and Biochemistry, The University of Tennessee Health Science CenterDepartment of Medicine, Division of Immunology and Rheumatology, Stanford University School of MedicineInstitute for Immunity, Transplantation and Infection, Stanford University School of MedicineDepartment of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford University School of MedicineInstitute for Immunology, Perelman School of Medicine, University of PennsylvaniaInstitute of Laboratory Medicine, Philipps University MarburgDepartment of Pathology and Laboratory Medicine, Perelman School of Medicine, University of PennsylvaniaDepartment of Medicine, Division of Immunology and Rheumatology, Stanford University School of MedicineInfection with SARS-CoV2 and the development of Coronavirus disease 2019 (COVID-19) has been linked to induction of autoimmunity and autoantibody production. Here the authors characterise the new-onset IgG autoantibody response in hospitalised patients with COVID-19 which they correlate to the magnitude of the SARS-CoV2 response.https://doi.org/10.1038/s41467-021-25509-3 |